| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.008 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |